Carvolix

Paris, France

Carvolix is develops innovative new-generation mini-invasive implants to restore essential physiological functions.

$9.3M raised

Jul 2024

Post-IPO Equity

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Carvolix raised?

Carvolix has raised $9.3M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in July 2024.

Who are Carvolix's investors?

Carvolix's investors include Kreos Capital, Edwards Lifesciences.

Where is Carvolix headquartered?

Carvolix is headquartered in Paris, France.

What does Carvolix do?

Carvolix is develops innovative new-generation mini-invasive implants to restore essential physiological functions.

What stage is Carvolix at?

Carvolix is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 15, 2024.

MLA

"Carvolix — Funding & Investors." VCBacked, July 15, 2024, https://www.vcbacked.co/company/carvolix. Accessed July 3, 2026.

APA

VCBacked. (2024). Carvolix — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/carvolix

Wikipedia (cite web)

{{cite web |title=Carvolix — Funding & Investors |url=https://www.vcbacked.co/company/carvolix |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 15, 2024.